Prevalence of antiretroviral drug resistance mutations in chronically HIV–infected, treatment-naive patients: implications for routine resistance screening before …
RM Novak, L Chen, RD MacArthur… - Clinical infectious …, 2005 - academic.oup.com
Background. The prevalence of drug resistance among persons with newly acquired human
immunodeficiency virus (HIV) infection is well documented. However, it is unclear to what …
immunodeficiency virus (HIV) infection is well documented. However, it is unclear to what …
Prevalence of antiretroviral drug resistance mutations in chronically HIV-infected, treatment-naive patients: implications for routine resistance screening before …
RM Novak, L Chen, RD MacArthur, JD Baxter… - 2005 - pubmed.ncbi.nlm.nih.gov
Background The prevalence of drug resistance among persons with newly acquired human
immunodeficiency virus (HIV) infection is well documented. However, it is unclear to what …
immunodeficiency virus (HIV) infection is well documented. However, it is unclear to what …
Prevalence of antiretroviral drug resistance mutations in chronically HIV-infected, treatment-naive patients: implications for routine resistance screening before …
RM Novak, L Chen, RD MacArthur, JD Baxter… - 2005 - cabidigitallibrary.org
Background: The prevalence of drug resistance among persons with newly acquired human
immunodeficiency virus (HIV) infection is well documented. However, it is unclear to what …
immunodeficiency virus (HIV) infection is well documented. However, it is unclear to what …
[引用][C] Prevalence of antiretroviral drug resistance mutations in chronically HIV-infected, treatment-naive patients: Implications for routine resistance screening before …
RM NOVAK, LI CHEN… - Clinical infectious …, 2005 - pascal-francis.inist.fr
Prevalence of antiretroviral drug resistance mutations in chronically HIV-infected, treatment-naive
patients: Implications for routine resistance screening before initiation of antiretroviral …
patients: Implications for routine resistance screening before initiation of antiretroviral …
[PDF][PDF] Prevalence of Antiretroviral Drug Resistance Mutations in Chronically HIV–Infected, Treatment-Naive Patients: Implications for Routine Resistance Screening …
RM Novak, L Chen, RD MacArthur… - Clinical Infectious …, 2005 - academia.edu
Background. The prevalence of drug resistance among persons with newly acquired human
immunodeficiency virus (HIV) infection is well documented. However, it is unclear to what …
immunodeficiency virus (HIV) infection is well documented. However, it is unclear to what …
Prevalence of antiretroviral drug resistance mutations in chronically HIV-infected, treatment-naive patients: implications for routine resistance screening before …
RM Novak, L Chen, RD MacArthur… - … Diseases: an Official …, 2005 - europepmc.org
Background The prevalence of drug resistance among persons with newly acquired human
immunodeficiency virus (HIV) infection is well documented. However, it is unclear to what …
immunodeficiency virus (HIV) infection is well documented. However, it is unclear to what …
Prevalence of antiretroviral drug resistance mutations in chronically HIV-infected, treatment-naive patients: Implications for routine resistance screening before …
RM Novak, RD MacArthur… - Clinical Infectious …, 2005 - augusta.elsevierpure.com
Background. The prevalence of drug resistance among persons with newly acquired human
immunodeficiency virus (HIV) infection is well documented. However, it is unclear to what …
immunodeficiency virus (HIV) infection is well documented. However, it is unclear to what …
Prevalence of antiretroviral drug resistance mutations in chronically HIV-infected, treatment-naive patients: Implications for routine resistance screening before …
RM Novak, L Chen, RD MacArthur… - Clinical Infectious …, 2005 - experts.umn.edu
Background. The prevalence of drug resistance among persons with newly acquired human
immunodeficiency virus (HIV) infection is well documented. However, it is unclear to what …
immunodeficiency virus (HIV) infection is well documented. However, it is unclear to what …
[PDF][PDF] Prevalence of Antiretroviral Drug Resistance Mutations in Chronically HIV–Infected, Treatment-Naive Patients: Implications for Routine Resistance Screening …
RM Novak, L Chen, RD MacArthur… - Clinical Infectious …, 2005 - scholar.archive.org
Background. The prevalence of drug resistance among persons with newly acquired human
immunodeficiency virus (HIV) infection is well documented. However, it is unclear to what …
immunodeficiency virus (HIV) infection is well documented. However, it is unclear to what …
Prevalence of Antiretroviral Drug Resistance Mutations in Chronically HIV-Infected, Treatment-Naive Patients: Implications for Routine Resistance Screening before …
RM Novak, L Chen, RD MacArthur, JD Baxter… - Clinical Infectious …, 2005 - JSTOR
Background. The prevalence of drug resistance among persons with newly acquired human
immunodeficiency virus (HIV) infection is well documented. However, it is unclear to what …
immunodeficiency virus (HIV) infection is well documented. However, it is unclear to what …